Clinical trials
Breast - Female clinical trials
Below are recruiting breast - female clinical trials, each written for real people, not researchers. We’re tracking 3,616 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06942234RecruitingPhase 1/Phase 2
Study of JSKN016 for advanced HER2-negative breast cancer
This trial tests a new combination drug (JSKN016) for people with HER2-negative breast cancer that has spread or cannot be removed. It is for those who have not yet had advanced-stage treatment (except hormone therapy) and may offer a new option.
ShanghaiAges 18–75 - NCT03547232RecruitingPhase 4
Indomethacin given early to treat acute pancreatitis
This trial tests whether taking indomethacin (an anti-inflammatory medicine) early can improve outcomes in people with acute pancreatitis. You might be eligible if your pancreatitis is diagnosed soon and you meet specific lab, imaging, and safety requirements.
Beijing, Beijing MunicipalityAges 18–80 - NCT04292067Recruiting
Study gut bacteria in people with arthritis
This study compares the gut microbiome (the bacteria in your intestines) in adults with spondyloarthritis or rheumatoid arthritis versus healthy adults. It aims to better describe differences that may help explain these diseases.
Boulogne-BillancourtAges 18 years+ - NCT06634108RecruitingPhase 1/Phase 2
Genistein for heart failure from ATTR amyloid cardiomyopathy
This trial tests whether genistein, a plant-based supplement, can help people with a specific type of heart disease called ATTR amyloid cardiomyopathy. You might join if you have heart failure with reduced pumping function and this rare protein condition.
London, OntarioAges 40–80 - NCT06832202RecruitingPhase 2
HLX22 plus Enhertu for HR+, HER2-low breast cancer
This trial tests a new drug, HLX22, combined with Enhertu (trastuzumab deruxtecan) for people with advanced breast cancer that is hormone receptor positive and HER2-low. The goal is to see if the combination works better than Enhertu alone.
Shanghai, Shanghai MunicipalityAges 18 years+ - NCT06937996Recruiting
NanoKnife treatment for advanced pancreatic cancer
This trial studies a procedure called NanoKnife IRE for pancreatic cancer that cannot be removed surgically after standard chemotherapy or radiation. It uses electric pulses to destroy tumor cells and may be an option for patients who have completed other treatments.
Englewood, New JerseyAges 18 years+ - NCT06934642RecruitingEarly Phase 1
A study of tirzepatide for fatty liver disease in people with obesity
This trial tests if tirzepatide, a diabetes and weight loss medication, can help improve fatty liver disease in people who are overweight or have obesity. It may offer a new treatment option for managing liver health.
Albuquerque, New MexicoAges 18–75 - NCT06934239RecruitingPhase 4
AI-assisted vs. standard mammograms for breast cancer screening
This trial compares standard mammograms with mammograms aided by artificial intelligence (AI) to see if AI helps find breast cancer more accurately and reduces unnecessary callbacks. If you're 18 or older and getting a routine screening mammogram at one of the six participating health systems, you may be eligible.
Los Angeles, CaliforniaAges 18 years+ - NCT06937710Recruiting
Return to sport after hip arthroscopy
This trial studies how the hip moves and works after hip arthroscopy (a keyhole surgery to fix a torn labrum). It aims to help athletes like you return to sport safely.
MérignacAges 18–50 - NCT06934564Recruiting
Cutting unnecessary tests before low-risk surgeries
This study helps surgical teams cut down on unnecessary tests before common low-risk surgeries, like breast lump removal, gallbladder removal, or hernia repair. It aims to improve patient care by reducing extra, unneeded procedures.
Ann Arbor, MichiganAges 18 years+ - NCT06940388RecruitingPhase 2
Immunotherapy plus standard treatment for rectal cancer
This trial is testing whether adding the immunotherapy drug tislelizumab to standard total neoadjuvant treatment (chemotherapy and radiation before surgery) can improve outcomes for people with locally advanced rectal cancer. The goal is to see if the combination helps shrink the tumor more than standard treatment alone.
MainzAges 18 years+ - NCT02843945RecruitingPhase 1/Phase 2
Testing radiation for borderline pancreatic surgery using a tiny implant
This early trial studies whether adding targeted radiation during or around pancreatic surgery is safe and may improve outcomes for people with borderline resectable pancreatic cancer. It is mainly looking at feasibility and safety while treating close to the tumor but not spreading (no metastasis).
Tampa, FloridaAges 18 years+ - NCT04646083Recruiting
Tests how far a scope can insert in the small bowel
This trial looks at how deeply doctors can safely insert a camera scope into the ileum (a part of the small intestine) during a procedure called retrograde enteroscopy. It may help improve how the exam is done for people whose small-bowel problem wasn’t fully found by usual tests.
El Paso, TexasAges 18–90 - NCT06738849Recruiting
Testing an app for insulin dosing
This trial tests the EkiYou smartphone app to help calculate your mealtime insulin dose. You need to have diabetes, use both a long-acting and a short-acting insulin pen, and be comfortable with a CGM and a smartphone.
BobignyAges 18 years+ - NCT06931769Recruiting
Optimizing treatment for stage III triple-negative breast cancer
This trial studies the best ways to give chemotherapy before and after surgery for stage III triple-negative breast cancer. It aims to improve treatment outcomes by using a personalized approach and patient-reported data.
Enschede, OverijsselAges 18 years+ - NCT06928818Recruiting
T-DM1 after T-DXd for advanced HER2-positive breast cancer
This trial looks at whether a different targeted therapy, T-DM1, can work for women with advanced HER2-positive breast cancer after they have already tried another targeted therapy called T-DXd (Enhertu). If you have progressed while on T-DXd and have not had more than three previous treatments for advanced cancer, you may be able to join.
SeoulAges 19 years+ - NCT06925217Recruiting
Closed-loop insulin for type 2 diabetes and kidney disease
This study tests whether a special type of insulin delivery system (closed-loop) can help people with type 2 diabetes and chronic kidney disease. You'll wear a continuous glucose monitor and insulin pump, and researchers will track how your kidneys respond over time.
Lausanne, Canton of VaudAges 18 years+ - NCT06925984Recruiting
Targeted radiation for breast cancer that has spread and is growing a little
This trial tests whether giving focused, high-dose radiation to spots where the cancer is growing can help control the disease while you stay on your current hormone therapy and/or CDK4/6 inhibitor. It is for people with ER+/HER2- breast cancer that has spread to a few places and is slowly starting to progress.
BrusselsAges 18 years+ - NCT06924788Enrolling by invitation
Stress management for breast cancer survivors via video
This study tests if stress management and relaxation training through video calls can help breast cancer survivors who live in under-resourced neighborhoods. It aims to improve emotional well-being and coping.
Birmingham, AlabamaAges 19 years+ - NCT06929091Recruiting
Breastfeeding help for women with higher weight
This study tests if expressing milk before birth and following a meal plan after birth helps women with higher weight breastfeed longer. You may join if you are pregnant, interested in breastfeeding, and live in Central Arkansas.
Little Rock, ArkansasAges 18 years+ - NCT06923267Recruiting
Ultrasound to check heart function during breathing trials
This trial tests if using ultrasound to monitor your heart during a breathing test can help predict if you will need the breathing tube again. It is for people on a ventilator for at least 24 hours who are at higher risk of needing the tube reinserted.
OrléansAges 18 years+ - NCT06931457Recruiting
Radiofrequency with platelet injection for nerve pain in the throat
This study tests if combining pulsed radiofrequency (a treatment that uses heat to calm nerve pain) with a platelet injection (using your own blood to help healing) is safe and works better for treating throat nerve pain (glossopharyngeal neuralgia) than radiofrequency alone.
Beijing, Beijing MunicipalityAges 18 years+ - NCT06928766RecruitingPhase 2
Sleep aids for people with sleep apnea and insomnia
This trial tests two sleep medications, eszopiclone and lemborexant, to see if they can improve sleep quality in people who have both obstructive sleep apnea (where breathing stops during sleep) and trouble falling or staying asleep. It may help if you have mild sleep apnea and a low threshold for waking up easily.
Bedford Park, South AustraliaAges 18 years+ - NCT06927050Recruiting
Visual tool to help understand cancer treatment choices
This study tests a digital tool that uses pictures and simple visuals to help you understand your cancer treatment options. The goal is to make the experience better for you, your family, and your doctors.
New York, New YorkAges 18–100
Hear when a new Breast - Female trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for breast - female?
- Yes. Clin2 currently lists 3,616 recruiting breast - female studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a breast - female trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a breast - female trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.